SPINK1 Gene Curation
Gene-disease assertions not curated here (add link or write note):
Disease | Chronic pancreatitis |
---|---|
Inheritance | Autosomal dominant |
Prevalence |
Source: |
Rapid or full curation? | Rapid Full |
ClinGen - dosage sensitivitiy, sufficient evidence for haploinsufficiency. GenCC - only US lab is Invitae (strong). No BabySeq. | |
Clinical Validity Scoring Notes and points | From Dosage sensitivity:
Source: |
Clinical Validity Points Total | 12 Source: |
Clinical Validity Classification Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed | Definitive Source: |
Molecular Mechanism Loss of function Gain of function Dominant negative Unknown Other | Loss of function
|
Penetrance Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) (list source/PMID) |
Source: |
Age of Onset Congenital Pediatric Adolescent Adulthood Late adulthood (list source/PMID) |
|
Severity |
|
Clinical Features |
Sources: |
HPO Terms |
|
Gene SOPs & Notes | LINK if SOP is a long document. Short notes if it is easy to digest. eg. Last known truncating variant |
Curation Summary | The SPINK1 gene is associated with autosomal dominant chronic pancreatitis, which is is characterized by inflammation of the pancreas. Symptoms can include abdominal pain, steatorrhea, abdominal symptoms (bloating, gas, cramps, diarrhea), elevated serum amylase or lipase, systemic inflammation, and multiorgan failure (PMID: 24624459). Risk factors for chronic pancreatitis include smoking, alcohol use, and genetic risk. |
Case ID, Curator name, Date, Jira ticket link | AO 01.24.25 56752207081045 |